Company: SLMT
Filing Date: 2025-09-05
Form Type: 6-K
Source: 0001213900-25-085112
Chunk: 0

Company: Brera Holdings PLC
Filing Date: 2025-09-05
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

For the month of September, 2025.

Commission File Number 001-41606

BRERA HOLDINGS PLC

(Translation of registrant’s name into English)

Connaught House, 5th Floor

One Burlington Road

Dublin 4

D04 C5Y6

Ireland

(Address of principal executive office)</div>

Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:

<div align='center'>Form 20-F ☒
Form 40-F ☐</div>

On September 3, 2025, Pietro Bersani gave written notice to Brera
Holdings PLC (the “Company”) of his resignation from his positions with the Company as Chief Executive Officer and Chief Financial
Officer, effective immediately. Mr. Bersani’s resignation was not a result of any disagreement relating to the Company’s operations,
policies or practices.

On September 3, 2025,
the board of directors of the Company (the “Board”) appointed Dr. Fabio Scacciavillani as Chief Executive Officer and Chief
Financial Officer, effective immediately. Dr. Scacciavillani will continue to serve as a director of the Company, but will no longer
serve on the Audit Committee, the Compensation Committee, and Nominating and Corporate Governance Committee or as chair of the Audit Committee.
Pursuant to a consulting agreement between the Company and Dr. Scacciavillani (the “Scacciavillani Consulting Agreement”),
Dr. Scacciavillani will be paid an annual salary of $400,000 per year, payable on the first of each month, and will be granted a restricted
share award under the Brera Holdings PLC 2022 Equity Incentive Plan (the “Plan”) of 30,000 Class B Ordinary Shares, $0.05
nominal value per share, of the Company (the “Class B Ordinary Shares”), vesting equally over three years. Dr. Scacciavillani
will also be eligible to receive a performance bonus at the discretion of the Compensation Committee.